Acta Ophthalmologica 2014
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion Alireza Ramezani,1,2 Hamed Esfandiari,1 Morteza Entezari,1 Siamak Moradian,1 Masoud Soheilian,1 Babak Dehsarvi1 and Mehdi Yaseri1,3 1 Department of Ophthalmology, Ophthalmic Research Center, School of Medicine, Labbafinejad and Imam Hossein Medical Centers, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3 Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences, Tehran, Iran
ABSTRACT. Purpose: To evaluate the effects of repeated intravitreal injections of bevacizumab (IVB) versus triamcinolone acetonide (IVT) in the treatment of acute central retinal vein occlusion (CRVO). Methods: In this randomized clinical trial, 86 eyes with recent onset (
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion Alireza Ramezani,1,2 Hamed Esfandiari,1 Morteza Entezari,1 Siamak Moradian,1 Masoud Soheilian,1 Babak Dehsarvi1 and Mehdi Yaseri1,3 1 Department of Ophthalmology, Ophthalmic Research Center, School of Medicine, Labbafinejad and Imam Hossein Medical Centers, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3 Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences, Tehran, Iran
ABSTRACT. Purpose: To evaluate the effects of repeated intravitreal injections of bevacizumab (IVB) versus triamcinolone acetonide (IVT) in the treatment of acute central retinal vein occlusion (CRVO). Methods: In this randomized clinical trial, 86 eyes with recent onset (
